Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

Pulmonary infections in critically ill patients are common and are associated with high morbidity and mortality. Piperacillin–tazobactam is a frequently used therapy in critically ill patients with pulmonary infection. Antibiotic concentrations in the lung reflect target‐site antibiotic concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Felton, T W, McCalman, K, Malagon, I, Isalska, B, Whalley, S, Goodwin, J, Bentley, A M, Hope, W W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169708/
https://www.ncbi.nlm.nih.gov/pubmed/24926779
http://dx.doi.org/10.1038/clpt.2014.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169708/
https://www.ncbi.nlm.nih.gov/pubmed/24926779
http://dx.doi.org/10.1038/clpt.2014.131

Ejemplares similares